Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 8
Submit an article Journal homepage
6,739
Views
19
CrossRef citations to date
0
Altmetric
Review

Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinion

Janny E. LommertsDepartment of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The NetherlandsView further author information
,
Marcel W. BekkenkDepartment of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The NetherlandsView further author information
&
Rosalie M. LuitenDepartment of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, The NetherlandsCorrespondence[email protected]
View further author information
Pages 883-888 | Received 27 Nov 2020, Accepted 07 Apr 2021, Published online: 27 Apr 2021

Figures & data

Figure 1. Clinical presentation of melanoma-associated vitiligo

A, Confetti-like depigmentation with hypochromic and depigmented areas. B, Similar presentation to non-segmental vitiligo with depigmentations in axilla and halo nevi. C1 and C2, Depigmentations on sun-exposed areas. D, Leucotrichia (whithening of hairs).
Figure 1. Clinical presentation of melanoma-associated vitiligo

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.